TLR3 and Mental deterioration: Importantly, dsRNA/TLR3 inhibitors could also reverse the cognitive decline after CCI by blocking the binding of dsRNAs and TLR3, suggesting that the binding of dsRNAs and TLR3 was crucial for the progression of cognitive disturbance after chronic neuropathic pain.